Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
DTP-HepB vaccine
Другие языки:

    DTP-HepB vaccine

    Подписчиков: 0, рейтинг: 0
    DTP-HepB
    Combination of
    DTP vaccine Vaccine
    Hepatitis B vaccine Vaccine
    Clinical data
    Trade names Tritanrix-HepB
    AHFS/Drugs.com UK Drug Information
    Routes of
    administration
    Intramuscular injection
    ATC code
    Identifiers
    CAS Number

    DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B.

    A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014.

    A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and Hib vaccine administered separately and pentavalent DTP-HepB-Hib vaccine.


    Новое сообщение